Eli Lilly & Co. (LLY) Misses Q1 EPS by 7c; Guides Raised
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,209.00 -0.92%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.62, $0.07 worse than the analyst estimate of $1.69. Revenue for the quarter came in at $6.96 billion versus the consensus estimate of $6.84 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2023 EPS of $8.65-$8.85, versus the consensus of $8.45.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
